Jiao-Tai-Wan Ameliorates the Insulin Resistance and Lipid Metabolism in T2DM Rats by Regulating Neurotransmitters

Jianhua Chen, Ziqi Jing, Xue Wang, Li Chu, Yanyi Li, Zhihui Li, Pengkai Ma, Yujie ZhangResearch 2021 · DOI

Introduction

Type 2 Diabetes Mellitus (T2DM) is a complex metabolic disease characterized by insulin resistance and β-cell dysfunction. While traditionally managed through glycemic control, recent research highlights the significant role of neuroendocrine disorders in the progression of the disease. Jiao-Tai-Wan (JTW), a traditional Chinese medicine formula composed of Rhizoma Coptidis and Cortex Cinnamomi, has shown promise in treating T2DM, yet its underlying mechanisms remain poorly understood. This study investigates whether JTW exerts its hypoglycemic and lipid-lowering effects by rebalancing neurotransmitter distribution across various tissues.

Methods

The researchers employed a high-fat diet and streptozotocin-induced T2DM rat model. Rats were treated with JTW for four weeks, with metformin used as a positive control. The study utilized a multi-faceted analytical approach:

Neurotransmitter Profiling

To map the distribution of key neurotransmitters, the team used Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS). This allowed for the precise quantification of serotonin (5-HT), epinephrine (E), norepinephrine (NE), dopamine (DA), and γ-aminobutyric acid (GABA) across the brain, heart, liver, kidney, adrenal glands, intestine, blood, and urine.

Table 1: UPLC-MS/MS parameters for the detection of neurotransmitters and internal standards.

Molecular Analysis of Transporters

To understand the regulation of these neurotransmitters, the expression of their respective transporters—SERT, DAT, NET, and GAT-1—was analyzed using quantitative Real-Time PCR (qRT-PCR) and Western Blotting. These "pumps" are critical for maintaining neurotransmitter homeostasis by facilitating their reuptake into cells.

Table 2: Primer sequences used for qRT-PCR analysis of neurotransmitter transporters.

Results

Metabolic Improvements

JTW treatment significantly improved glucose homeostasis and insulin sensitivity, as evidenced by reduced fasting blood glucose and HOMA-IR scores. Furthermore, JTW ameliorated lipid metabolism disorders, reducing serum triglycerides and LDL-C while increasing HDL-C. Pathological examinations also showed reduced fat accumulation and structural damage in the liver and kidneys.

Rebalancing the Neuroendocrine System

The study revealed that T2DM causes a systemic imbalance in neurotransmitter levels. For instance, 5-HT levels were significantly lower in the brain but higher in the adrenal glands and blood of diabetic rats. JTW treatment effectively reversed these trends, shifting neurotransmitter concentrations back toward healthy levels.

Regulation of Transporter Expression

Mechanistically, JTW was found to modulate the expression of neurotransmitter transporters in the brain and kidney. In T2DM rats, the mRNA and protein levels of SERT, DAT, and GAT-1 were significantly elevated, while NET expression was decreased. JTW treatment successfully downregulated SERT, DAT, and GAT-1 and upregulated NET, suggesting that its therapeutic effect is mediated through the restoration of transporter-driven neurotransmitter homeostasis.

Conclusion

This research provides a novel neuroendocrine perspective on the efficacy of Jiao-Tai-Wan in treating T2DM. By targeting the "pumps" that regulate neurotransmitter distribution, JTW addresses the systemic metabolic chaos associated with diabetes. While further studies are needed to identify the specific active compounds within JTW, these findings highlight the potential of TCM formulas to treat complex metabolic diseases through multi-target regulation.

Reference: Chen, J., et al. (2021). Jiao-Tai-Wan Ameliorates the Insulin Resistance and Lipid Metabolism in T2DM Rats by Regulating Neurotransmitters. Research Square (Preprint). DOI: 10.21203/rs.3.rs-857847/v1

Summary updated

Abstract

Abstract Background: Type 2 diabetes mellitus (T2DM) is a metabolic disease characterized by insulin resistance and β-cell dysfunction, and accompanied by neuroendocrine disorders. Recently, Jiao-Tai-Wan (JTW) has been reported to exert hypoglycemic effects against diabetes. However, its mechanism has not been clarified. Therefore, we attempted to explore the effect of JTW on alleviating insulin resistance and lipid metabolism disorder in T2DM rats by regulating the level of neurotransmitters. Methods: Sprague-Dawley (SD) rats were treated with a high-fat diet/streptozotocin to induce T2DM and then gavaged with JTW for 4 weeks. Afterwards, endpoints including body weight, fasting blood glucose, glucose tolerance, serum insulin, and lipid index were determined, and we analyzed pathological changes in the liver and kidney. Meanwhile, the level of neurotransmitter neurotransmitters in the central nervous system and peripheral tissues was measured by UPLC-MS/MS. Furthermore, the expression of neurotransmitter transporter mRNA and protein levels in the brain and kidney of T2DM rats was analyzed by qRT-PCR and WB. Results: The results showed that JTW ameliorated glucose homeostasis, insulin resistance, and lipid metabolism in T2DM rats by regulating the disorder of neurotransmitter distribution in the brain, kidney, intestine, adrenal gland, blood, and urine of T2DM rats. Mechanically, JTW may improve neurotransmitter disturbance by reducing mRNA and protein expression of SERT, DAT, and GAT-1 and increasing mRNA and protein expression of NET in the brain and kidney of T2DM rats. Conclusion: Our findings confirm that JTW can play a hypoglycemic role by regulating the disorder level of neurotransmitter distribution in T2DM rats, which may have potential therapeutic implications for the treatment of T2DM.
BibTeX
@inproceedings{chen2021jiao,
  author = {Jianhua Chen and Ziqi Jing and Xue Wang and Li Chu and Yanyi Li and Zhihui Li and Pengkai Ma and Yujie Zhang},
  title = {{Jiao-Tai-Wan Ameliorates the Insulin Resistance and Lipid Metabolism in T2DM Rats by Regulating Neurotransmitters}},
  booktitle = {Research},
  year = {2021},
  doi = {10.21203/rs.3.rs-857847/v1},
}
Figure